The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
Adenovirus vaccine vectors generated from new viral serotypes are routinely screened in pre-clinical laboratory animal models to identify the most immunogenic and efficacious candidates for further evaluation in clinical human and veterinary settings. Here, we show that studies in a laboratory speci...
المؤلفون الرئيسيون: | Dicks, M, Guzman, E, Spencer, A, Gilbert, S, Charleston, B, Hill, A, Cottingham, M |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Elsevier
2015
|
مواد مشابهة
-
Uncovering the mechanisms of adenovirus vector immunogenicity
حسب: Dicks, M, وآخرون
منشور في: (2013) -
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
حسب: Dicks, M, وآخرون
منشور في: (2012) -
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
حسب: Dicks, M, وآخرون
منشور في: (2015) -
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
حسب: Matthew D J Dicks, وآخرون
منشور في: (2012-01-01) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
حسب: Warimwe, G, وآخرون
منشور في: (2013)